News

The role of the SMYD3 enzyme in driving prostate cancer progression has been identified, making it a prime drug target for preventing metastatic disease.

Instead of building a carbon skeleton from scratch to make new compounds, UChicago scientists have developed a new method where they can insert atoms within an already existing carbon framework.

Using a type of artificial intelligence known as deep learning, MIT researchers have discovered a class of compounds that can kill a drug-resistant bacterium that causes more than 10,000 deaths in the United States every year.

Researchers have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.

University of Virginia Alzheimer’s researchers have discovered how harmful tau proteins damage the essential operating instructions for our brain cells, a finding which could lead to new treatments.

Human organ chip research shows that a common antimalarial combination could reverse the negative effects of malnutrition in the female digestive tract that lead to low birth weight infants.

A collaborative team of researchers announced that they had successfully learned how to sabotage a key piece of machinery, called the Type 3 secretion system, that pathogens use to infect their host cells.

Screening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized trials suggest, according to a study co-authored by an MIT economist that takes a new look at data from five trials.

A new review has called into question how effective opioids are for cancer pain, finding non-opioids, including aspirin, may be just as effective.

A newly developed vaccine could offer an inexpensive way to lower "bad" cholesterol, improving heart health.